Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency;Efficacia del trattamento topico con mesoglicano nelle ulcere degli arti inferiori in soggetti con insufficienza venosa cronica

Minerva Cardioangiologica

Volumn 47, Issue 9, 1999, Pages 315-319

  La Marca, G ^a   Pumilia, G ^a   Martino, A ^a  

^a Azienda Ospedaliera Civico F   (Italy)

Author keywords

Glucosaminoglycans; Varicose ulcer; Venous insufficiency

Indexed keywords

MESOGLYCAN; NIKETHAMIDE;

ADULT; AGED; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LEG ULCER; MALE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; ULCER HEALING;

ADMINISTRATION, TOPICAL; AGED; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; LEG ULCER; MALE; MIDDLE AGED; VARICOSE ULCER;

EID: 0032736059     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cornwall JV, Dorè CJ. Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986;73:693.
2. Baker SR, Stacey MC, Singh G, Hoskin SE, Thompson PJ. Aethiology of chronic leg ulcers. Eur J Vasc Surg 1992;6:245-51.
3. Abbadini M, Jin Zhu G, Maggi A, Pangrazzi J, Donati MB, Mussoni L. Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters. Blood 1987;70:1858-60.
4. Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood 1984:64(3): 742-6.
5. Blajchman MA, Young E, Ofosu FA. Effects of unfractionated heparin, dermatansulfate and low molecular weight heparin on vessel wall permeability in rabbits. Ann N Y Acad 1989:245-57.
6. Agrifoglio G, Di Perri T, Strano A. Studio multicentrico sull'efficacia e la tollerabilità del mesoglicano in pazienti affetti da malattia venosa. Farmaci 1989;13:1-9.
7. Aluigi L, Rocchi P, Tamburini M, Accorsi F. Ridoilfi C. Efficacia del mesoglicano nel trattamento dell'insufficienza venosa cronica. GIR 1991;12(6):147.
8. Andreozzi GM, Signorelli S, Martini R, Palazzo V, Garozzo G, Sciuto V et al. Effetti protettivi del mesoglicansolfato sulla trombogenesi venosa. Minerva Med 1986;77:1883-6.
9. Odero A, Tinozzi S. Studio controllato sull'efficacia del trattamento con mesoglicano in pazienti affetti da insufficienza venosa cronica e/o sindrome varicosa degli arti inferiori. Farmaci 1992;16(7-8):23-8.
10. Croce P, Sanzone E, Barresi A, Iapichino G. Trattamento delle ulcere post-flebitiche con mesoglicano ad alte dosi. Gazz Med It 1987;146:273-7.
11. Ruck F, Valenghi D, Agostini M, Morotti L. Venous ulcers at lower limbs: treatment with mesoglicano for topical and systemic use. Phlebologie 1992:1312-4.
12. Lotti T, Celasco G, Tsampau D, Teofoli P, Benci M. Mesoglycan treatment restores defective fibrinolytic potential in curaneous necrotizing venulitis. Int J Dermatol 1993;32:368-71.